Efficacy and Safety of Neoadjuvant Surufatinib for Patients With Salivary Gland Carcinomas
Clinical trial NCT05013515 · UNKNOWN
Trial details
- NCT number
- NCT05013515
- Sponsor
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-01
- Primary completion
- 2022-09-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.